These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25091850)

  • 1. Baseline mortality-adjusted survival in resected rectal cancer patients.
    Tarantino I; Müller SA; Warschkow R; Kulu Y; Schmied BM; Büchler MW; Ulrich A
    J Gastrointest Surg; 2014 Oct; 18(10):1837-44. PubMed ID: 25091850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative survival is an adequate estimate of cancer-specific survival: baseline mortality-adjusted 10-year survival of 771 rectal cancer patients.
    Tarantino I; Achermann P; Güller U; Ulrich A; Schmied BM; Horber D; Cerny T; Stanga Z; Warschkow R
    Ann Surg Oncol; 2013 Nov; 20(12):3877-84. PubMed ID: 23907315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients.
    Tarantino I; Warschkow R; Worni M; Merati-Kashani K; Köberle D; Schmied BM; Müller SA; Steffen T; Cerny T; Güller U
    Br J Cancer; 2012 Jul; 107(2):266-74. PubMed ID: 22735902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis.
    Alsughayer A; Grass F; McKenna NP; Petersen M; Mathis KL; Lightner AL
    Dis Colon Rectum; 2020 Sep; 63(9):1265-1275. PubMed ID: 33216497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anastomotic leakage is associated with impaired overall and disease-free survival after curative rectal cancer resection: a propensity score analysis.
    Kulu Y; Tarantio I; Warschkow R; Kny S; Schneider M; Schmied BM; Büchler MW; Ulrich A
    Ann Surg Oncol; 2015; 22(6):2059-67. PubMed ID: 25348782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical redo surgery for local rectal cancer recurrence improves overall survival: a single center experience.
    Schurr P; Lentz E; Block S; Kaifi J; Kleinhans H; Cataldegirmen G; Kutup A; Schneider C; Strate T; Yekebas E; Izbicki J
    J Gastrointest Surg; 2008 Jul; 12(7):1232-8. PubMed ID: 18446418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors for regional lymph node metastasis in T1 rectal cancer: a population-based SEER analysis.
    Brunner W; Widmann B; Marti L; Tarantino I; Schmied BM; Warschkow R
    Surg Endosc; 2016 Oct; 30(10):4405-15. PubMed ID: 26895892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis.
    Tarantino I; Warschkow R; Schmied BM; Güller U; Mieth M; Cerny T; Büchler MW; Ulrich A
    J Gastrointest Surg; 2016 Jun; 20(6):1213-22. PubMed ID: 27067235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of anastomotic leakage on long-term survival in mid-to-low rectal cancer].
    Jäger T; Nawara C; Neureiter D; Holzinger J; Öfner-Velano D; Dinnewitzer A
    Chirurg; 2015 Nov; 86(11):1072-82. PubMed ID: 26428227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
    Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
    Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative blood transfusions do not impact overall and disease-free survival after curative rectal cancer resection: a propensity score analysis.
    Warschkow R; Güller U; Köberle D; Müller SA; Steffen T; Thurnheer M; Schmied BM; Tarantino I
    Ann Surg; 2014 Jan; 259(1):131-8. PubMed ID: 23470578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
    Karagkounis G; Thai L; Mace AG; Wiland H; Pai RK; Steele SR; Church JM; Kalady MF
    Ann Surg; 2019 Jun; 269(6):1117-1123. PubMed ID: 31082910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of intersphincteric resection for low rectal cancer.
    Chamlou R; Parc Y; Simon T; Bennis M; Dehni N; Parc R; Tiret E
    Ann Surg; 2007 Dec; 246(6):916-21; discussion 921-2. PubMed ID: 18043092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline mortality-adjusted survival in colon cancer patients.
    Ukegjini K; Zadnikar M; Warschkow R; Müller S; Schmied BM; Marti L
    Langenbecks Arch Surg; 2016 Aug; 401(5):633-41. PubMed ID: 27102323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
    Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between mesorectal grading and oncological outcome in rectal adenocarcinoma.
    Silva-Velazco J; Stocchi L; Valente MA; Church JM; Liska D; Gorgun E; Kalady MF; Kessler H; Steele SR; Delaney CP
    Colorectal Dis; 2019 Mar; 21(3):315-325. PubMed ID: 30565830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Completely Abdominal Approach Laparoscopic Partial Intersphincteric Resection After Neoadjuvant Chemoradiation for Initial cT3 Juxta-Anal Rectal Cancer.
    Huang S; Huang Y; Chi P; Lin H; Lu X; Xu Z; Sun Y; Wang X
    J Laparoendosc Adv Surg Tech A; 2019 Jun; 29(6):809-816. PubMed ID: 30596539
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgeon-related factors and outcome in rectal cancer.
    Porter GA; Soskolne CL; Yakimets WW; Newman SC
    Ann Surg; 1998 Feb; 227(2):157-67. PubMed ID: 9488510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.